News

UMDNJ-Robert Wood Johnson Medical School held its Eighth Annual Student Clinician Ceremony on June 30, welcoming its third-year class into clinical training. The ceremony celebrates the art of practicing humanistic medicine and honors those residents who serve as role models and educate medical students on the importance of providing compassionate care to patients. The event is sponsored by the Arnold P. Gold Foundation.


UMDNJ Students "Bridge the Gaps"  

Six students from UMDNJ's School of Osteopathic Medicine, School of Public Health, and Graduate School of Biomedical Sciences at the Stratford campus are participating in "Bridging the Gaps," a summer work/study program that helps three Camden area agencies - Camden Area Health Education Center (AHEC), Planned Parenthood and the Hope Outreach Center.

Each week, the students spend four days working in the community-based agencies. Cleaning parks, teaching teens about reproductive health, and helping adults with financial counseling are just a few of the service projects. They also spend a day in Philadelphia attending workshops with community members and health and social service professionals, which helps them develop a better understanding of key issues that affect the vulnerable populations living in urban communities.

This is the second summer that UMDNJ has participated in the Bridging the Gaps program, joining a consortium of area colleges, including the University of Pennsylvania, Temple University, Drexel and Thomas Jefferson University.

 

Cancer Institute of New Jersey Study Published in JAMA  

New research published in the July 9th issue of JAMA (Vol. 300, No. 2) by a team of investigators from The Cancer Institute of New Jersey (CINJ) shows that primary androgen deprivation therapy (PADT) does not improve overall survival rates over conservative therapy for localized prostate cancer in elderly men.

The researchers compared outcomes among more than 11,000 men given conservative management and 7,800 men given PADT for the treatment of stage T1 to T2 prostate cancer diagnosed between 1992 and 2002. All the men were 66 years of age or older.

CINJ is a Center of Excellence at UMDNJ-Robert Wood Johnson Medical School.